EUVIMEDEUVIMED entdecken
Crossref

Predicting and preventing Alzheimer’s disease

Eric Topol iD

Science · 29.05.2025 · 388 (6750)

DOI: 10.1126/science.ady3217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 29.05.2025. Verfasst von Eric Topol. Beteiligte Einrichtung: Eric Topol is director of the Scripps Translational Science Institute, La Jolla, CA USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Artificial Intelligence. Die Arbeit wurde bisher 21-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With all the advances in both the science of aging and artificial intelligence (AI), we are in a propitious position to accurately and precisely determine who is at high risk of developing Alzheimer’s disease years before signs of even mild cognitive deficit. It takes at least 20 years for aggregates of misfolded β-amyloid and tau proteins to accumulate in the brain along with neuroinflammation that they incite. This provides a long window of opportunity to get ahead of the pathobiological process, both for prediction and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseArtificial IntelligenceHumansAmyloid beta-PeptidesBrainCognitive Dysfunctiontau ProteinsApolipoprotein E4Risk

Substanzen

Amyloid beta-Peptidestau ProteinsApolipoprotein E4

Autor:innen und Institutionen

  • Eric Topol is director of the Scripps Translational Science Institute, La Jolla, CA USA.

ORCID-Profile: Eric Topol

Zitieren

APA

Topol, E. (2025). Predicting and preventing Alzheimer’s disease. Science, 388(6750). https://doi.org/10.1126/science.ady3217

Vancouver

Topol E. Predicting and preventing Alzheimer’s disease. Science. 2025;388(6750). doi:10.1126/science.ady3217

BibTeX
@article{Topol2025,
  author = {Topol, Eric},
  title = {Predicting and preventing Alzheimer’s disease},
  journal = {Science},
  year = {2025},
  volume = {388},
  number = {6750},
  doi = {10.1126/science.ady3217}
}
Kostenlos starten →